Science Explorer Interactive view Map
Company · Rome · Italy

Pfizer (Italy)

World rank, all time
#28,515
of 42,892
Rank in Italy
#787
of 969
Research works
154
▲ 15% vs 2013–17
Citations
5k
32.8 per fractional work
Top-10% rate
26.5%
record average 16.5%
Open access
46%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.31× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.19× its world share, 1 worksImmunology and Micro…Neuroscience: 0.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.64× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.42× its world share, 0 worksChemistryComputer Science: 0.11× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMathematics: 0.22× its world share, 0 worksMathematicsHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 3.90× its world share, 24 worksMedicineBusiness, Management and Accounting: 0.11× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.52× its world share, 1 worksEconomics, Econometr…Psychology: 0.23× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.

Which keywords describe research at Pfizer (Italy)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Immunotherapy, Chemotherapy, Targeted Therapy, Clinical Trials, Immune Response, SARS-CoV-2 and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Epidemiology6▲ 5.0×27 topics
  2. Immunotherapy3▲ 14×11 topics
  3. Chemotherapy3▲ 14×9 topics
  4. Clinical Trials2▲ 12×5 topics
  5. Targeted Therapy2▲ 35×4 topics
  6. Immune Response2▲ 13×5 topics
  7. SARS-CoV-22▲ 22×4 topics
  8. ACE2 Receptor2▲ 25×2 topics
  9. Pandemic2▲ 5.8×2 topics
  10. Prognostic Factors2▲ 15×6 topics
  11. Genomic Profiling2▲ 50×2 topics
  12. ALK Inhibitors2▲ 73×1 topic
  13. Cancer Therapy2▲ 8.1×5 topics
  14. EGFR Mutations2▲ 73×1 topic
  15. Thrombosis2▲ 16×3 topics
  16. Treatment Guidelines2▲ 22×2 topics
  17. Melanoma1▲ 71×2 topics
  18. Pathophysiology1▲ 14×3 topics
  19. Vaccine Development1▲ 17×2 topics
  20. Clinical Characteristics1▲ 32×2 topics
  21. Molecular Characterization1▲ 22×4 topics
  22. Viral Infections1▲ 70×2 topics
  23. Antiviral Treatment1▲ 35×1 topic
  24. Cytokine Storm1▲ 35×1 topic
  25. Human Metapneumovirus1▲ 82×1 topic
  26. Immunity1▲ 9.1×5 topics
  27. Minimal Residual Disease1▲ 55×2 topics
  28. Respiratory Syncytial Virus1▲ 82×1 topic
  29. Vaccine1▲ 9.6×4 topics
  30. Cognitive Impairment1▲ 13×2 topics
  31. Neoadjuvant Therapy1▲ 14×4 topics
  32. Tumor Microenvironment1▲ 7.7×6 topics
  33. Breast Cancer1▲ 13×4 topics
  34. Genetic Mutations1▲ 7.2×6 topics
  35. Neuropathology1▲ 24×2 topics

Which research topics does Pfizer (Italy) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, COVID-19 Clinical Research Studies, Respiratory viral infections research and Melanoma and MAPK Pathways.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  3. 3 Respiratory viral infections research Epidemiology 1 works
  4. 4 Melanoma and MAPK Pathways Molecular Biology 1 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  6. 6 Multiple Myeloma Research and Treatments Hematology 1 works
  7. 7 Long-Term Effects of COVID-19 Neurology 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Lung Cancer Research Studies Oncology 1 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.3%not open53.7%

World: 28% of research is openly available.

with international co-authors61.6%domestic only38.4%

World: 19% is written across borders.

How has Pfizer (Italy)'s research output changed?

Output in 2018–2022 was 15% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rome

All research institutions in Rome

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.